DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

NCT05620901 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Vitreoretinopathy
Coats' Disease
Exudative Retinopathy
Lattice Degeneration
Retinal Hole
Sickler's Syndrome
Retinal Detachment Rhegmatogenous
Retinal Detachment Exudative
Retinal Detachment Traction

Interventions

DRUG: Dextenza 0.4Mg Ophthalmic Insert
DRUG: Pred Forte

Sponsor

Lejla Vajzovic, MD, FASRS